Wednesday 24 Apr 2024
By
main news image

This article first appeared in The Edge Financial Daily on February 22, 2019

KUALA LUMPUR: Pharmaniaga Bhd's fourth quarter (4Q) net profit plunged by 80% to RM4.44 million from RM21.7 million a year ago mainly due to lower demand coupled with higher finance costs.

Earnings per share for the quarter ended Dec 31, 2018 fell to 1.71 sen from 8.36 sen previously, the group said in a filing to Bursa Malaysia.

Revenue fell by 3%  to  RM596.64 million compared with RM613.2 million a year ago.

It has declared a fourth interim dividend of two sen per share which will be paid on April 10, 2019.

 It also noted that during the year-ago fourth quarter, there was a one-off compensation receivable in relation to a previous joint venture company in China.

The full-year net profit also came in lower as a result, falling by 21% to RM42.47 million from RM53.82 million in the previous year, though revenue rose slightly by 3% to RM2.38 billion from RM2.32 billion.

      Print
      Text Size
      Share